Clinical efficacy of enhanced recovery surgery in Da Vinci robot-assisted pancreatoduodenectomy

作者：Zhenxing Liu, Honghong Chen, Zhengbiao Li, Jinlong Liang, Tao Zhang, Weiwei Ning, Jiwei Wang · 发表于：Scientific Reports · 年份：2024 · DOI：10.1038/s41598-024-72835-9 · 被引用次数：6 · 研究领域：Pancreatic and Hepatic Oncology Research、Enhanced Recovery After Surgery、Gastric Cancer Management and Outcomes

Da Vinci robot-assisted pancreaticoduodenectomy offers advantages, including minimal invasiveness, precise, and safe procedures. This study aimed to investigate the clinical effectiveness of implementing enhanced recovery after surgery (ERAS) concepts in Da Vinci robot-assisted pancreaticoduodenectomy. A retrospective analysis was conducted on clinical data from 62 patients who underwent Da Vinci robot-assisted pancreaticoduodenectomy between January 2018 and December 2022. Among these patients, 30 were managed with ERAS principles, while 32 were managed using traditional perioperative management protocols. Surgical time, intraoperative blood loss, postoperative oral intake time, time to return of bowel function, time to ambulation, visual analog scale (VAS) pain scores, fluid replacement volume, length of hospital stay, total hospital expenses, complications, and patient satisfaction were recorded and compared between the two groups. Postoperative follow-up included assessment of postoperative functional scores, reoperation rates, SF-36 quality of life scores, and survival rates. The average follow-up time was 35.6 months (range: 12-56 months). There were no statistically significant differences in general characteristics, including age, surgical time, intraoperative blood loss, and preoperative medical history between the two groups (P > 0.05). Compared to the control group, the intervention group had an earlier postoperative oral intake time, faster return of bowel functio...